HOME >> BIOLOGY >> NEWS
Israeli teams grows heart cells and insulin producing cells from human embryonic stem cells

Studies offer new hope for curing diabetes and heart disease

HAIFA, Israel and NEW YORK, N.Y., - Since the isolation of human embryonic stem cells three years ago, scientists have been excited about the prospect of using these cells to produce all the different types of tissues in our body, such as heart tissue to repair damaged hearts.

Now researchers at the Technion-Israel Institute of Technology have for the first time succeeded in growing the precursors of heart cells from human embryonic stems cells. This puts the researchers considerably closer to clinical application in humans. The research, conducted by Dr. Lior Gepstein of the Faculty of Medicine at the Technion-Israel Institute of Technology and Dr. Joseph Itskovitz-Eldor of the Faculty of Medicine and Rambam Medical Center, is published in the August Journal of Clinical Investigation.

In a second study, another team of researchers at the Technion-Israel Institute of Technology demonstrated that human embryonic stem cells can produce insulin, a result that could signal an important step toward a cure for type 1 diabetes. Their research, led by Dr. Karl Skorecki of the Faculty of Medicine at the Technion-Israel Institute of Technology, is published in the August Diabetes.

Type 1 diabetes is a disease that generally results from the autoimmune destruction of pancreatic islet cells, which produce the insulin that "unlocks" the cells of the body allowing glucose to enter and fuel them. The only way to cure the disease is by pancreas transplantation. However, due to the shortage of organ donations and other factors, there remains a greatly insufficient supply of organs.

The study "offers the promise that stem cells might provide a rich source of insulin-producing cells and put us closer to a cure for this serious disease," said Dr. Christopher D. Saudek, president of the American Diabetes Association.

While other researchers recently reported on the use
'"/>

Contact: Adar Novak
adar@ats.org
212-307-2519
American Society for Technion - Israel Institute of Technology
1-Aug-2001


Page: 1 2 3

Related biology news :

1. Israeli scientists reveal the plan of a key cellular machine
2. Study by Israeli scientists provides insight on DNA code
3. Scientists identify a gene causing a fatal heart condition, common in an Israeli Bedouin tribe
4. Israeli scientists block the progression of Type I diabetes
5. Israeli scientists discover gene responsible for hereditary muscle disease prevalent among Jews of Persian descent
6. Israeli fertility experts call for international chromosome registry
7. Dr. Robert C. Gallo to Collaborate with Visiting Israeli Scientist on Promising HIV Vaccine Research at Marylands Institute of Human Virology
8. Researchers develop white wine with cholesterol-lowering benefits, discover Israeli wines healthier than French wines
9. Hopkins, Israeli Scientists Link Soybeans With Pain Relief
10. Moffitt teams with DNAPrint(TM) to predict patient response to chemotherapy
11. B2MIN9: Beagle 2 teams continue efforts to communicate with the lander

Post Your Comments:
(Date:5/22/2015)... OXFORD, CT , May 22, 2015  NXT-ID, Inc. ... from June 1st, it will be ending its promotional pricing ... www.wocketwallet.com . Laurence Savin , Head of ... our exclusive promotional pricing until the end of May. To ... at wocketwallet.com/invite and when we open the store on June ...
(Date:5/20/2015)... , May 20, 2015 /PRNewswire/ ... http://www.researchandmarkets.com/research/h8t4x6/5year ) has announced the addition ... the Global Iris Recognition Market"  report ... , ,This research service analyses trends ... the government and commercial sectors, globally. ...
(Date:5/19/2015)... , May 19, 2015 ... has announced the addition of the  "Genetic ... offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,A recent ... an in-depth analysis of the current and ... of gene-based tests, their working principles and ...
Breaking Biology News(10 mins):NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 2NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 3Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2Global Genetic Testing Market Outlook 2018 2
(Date:5/26/2015)... May 26, 2015 Tianyin Pharmaceutical Inc. (NYSE ... in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), ... the Company,s Annual Meeting of Shareholders for fiscal year ... held at the Company,s office located in ... 9:00 AM (local time in Chengdu, China ...
(Date:5/26/2015)... 26, 2015 Pharmaco-Kinesis Corporation (PKC) announced today ... at Shutters on the Beach in Santa ... of the Company,s innovative Metronomic Biofeedback Pump (MBP), a ... chemotherapy over time to a target site of the ... biofeedback system in real-time.  ...
(Date:5/26/2015)... May 26, 2015 Oramed Pharmaceuticals ... clinical-stage pharmaceutical company focused on the development of oral ... the study protocol for the company,s Phase IIb trial ... Food and Drug Administration (FDA). The submission was made ... The Phase IIb study of ORMD-0801 for ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 Just the ... a long-standing unmet biomedical need does not guarantee immediate ... problem that has seen many prior failures is often ... acceptance and use is an irony that is often ... small, new start-up company, Asymmetrex has found ...
Breaking Biology Technology:TPI Adjourned Its 2014 Annual Shareholder Meeting and Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements 2TPI Adjourned Its 2014 Annual Shareholder Meeting and Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements 3Pharmaco-Kinesis Corporation Convenes Third Neuro-Oncology Clinical Advisory Board Meeting 2Pharmaco-Kinesis Corporation Convenes Third Neuro-Oncology Clinical Advisory Board Meeting 3Pharmaco-Kinesis Corporation Convenes Third Neuro-Oncology Clinical Advisory Board Meeting 4Pharmaco-Kinesis Corporation Convenes Third Neuro-Oncology Clinical Advisory Board Meeting 5Oramed Submits Protocol to U.S. FDA for Its Phase IIb Oral Insulin Study 2Oramed Submits Protocol to U.S. FDA for Its Phase IIb Oral Insulin Study 3In August Asymmetrex Will Present Details of Its Crowdsourcing Campaign to Determine the Extent of Application of New Technologies for Counting Adult Tissue Stem Cells 2In August Asymmetrex Will Present Details of Its Crowdsourcing Campaign to Determine the Extent of Application of New Technologies for Counting Adult Tissue Stem Cells 3
Cached News: